ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,053Medicare Part D Prescriptions Filled, Including Refills

Rank: 102 out of 324

$472K Total Retail Price of All Prescriptions

Rank: 114 out of 324

362 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
12% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 362 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 362 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 8,785 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
SIMVASTATIN 469 469 1 1
LISINOPRIL 351 350 2 3
LEVOTHYROXINE SODIUM 351 351 2 2
AMLODIPINE BESYLATE 261 261 4 4
OMEPRAZOLE 202 202 5 6
HYDROCODONE-ACETAMINOPHEN 182 173 S3 6 5
HYDROCHLOROTHIAZIDE 174 169 7 11
ZOLPIDEM TARTRATE 164 151 8 20
ATORVASTATIN CALCIUM 162 152 9 12
BUMETANIDE 134 134 10 82
METOPROLOL SUCCINATE 134 134 10 17
MELOXICAM 130 130 12 29
LOSARTAN POTASSIUM 122 120 13 15
CRESTOR 121 121 14 28
GABAPENTIN 121 121 14 13
SERTRALINE HCL 118 118 16 23
FUROSEMIDE 115 106 17 7
CITALOPRAM HBR 113 113 18 16
ALLOPURINOL 108 108 19 27
WARFARIN SODIUM 101 77 20 10
POTASSIUM CHLORIDE 100 100 21 8
METOPROLOL TARTRATE 98 98 22 14
PRAVASTATIN SODIUM 98 97 22 21
METFORMIN HCL 82 80 24 9
EVISTA 81 76 25 116
FLUTICASONE PROPIONATE 78 76 26 32
TAMSULOSIN HCL 75 65 27 26
NAMENDA 71 71 28 31
ALENDRONATE SODIUM 70 63 29 24
CIPROFLOXACIN HCL 67 67 30 55
TRAMADOL HCL 67 67 30 19
AGGRENOX 63 63 32 162
DONEPEZIL HCL 60 60 33 25
DICLOFENAC SODIUM 58 58 34 114
CARVEDILOL 57 57 35 22
AZITHROMYCIN 55 55 36 48
BENAZEPRIL HCL 53 53 37 75
SYNTHROID 53 52 37 30
CLOPIDOGREL 53 53 37 38
AMLODIPINE BESYLATE-BENAZEPRIL 52 52 40 100
ACETAMINOPHEN-CODEINE 52 52 S3 40 188
FAMOTIDINE 52 52 40 62
LORAZEPAM 51 51 43 368
ATENOLOL 51 47 43 18
DOXYCYCLINE HYCLATE 50 50 45 78
NEXIUM 50 50 45 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 10, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.